Table 3.
Regression Analyses of Disease-Specific Risk Factors for Depression and Anxiety in SLE/MCTD and T1D Subjects
| Risk Factor | Depression OR (95% CI) | Anxiety OR (95% CI) |
|---|---|---|
| SLE/MCTD | ||
| SLEDAI | 1.1 (1.1-1.2) p<0.001 | 1.0 (0.9-1.2) p=0.47 |
| SDI | ||
| No damage (score=0) | -- | -- |
| Damage (score>0) | 2.7 (0.9-7.7) p=0.07 | 1.7 (0.5-5.1) p=0.37 |
| Prednisone equivalent daily dose | 1.0 (0.9-1.1) p=0.67 | 1.0 (0.9-1.1) p=0.99 |
| T1D | ||
| HbA1c | 1.3 (1.03-1.55) p=0.02 | 1.2 (0.9-1.5) p=0.14 |
| Blood glucose checks/day | ||
| 4 or less | -- | -- |
| > 4 | 0.7 (0.2-1.7) p=0.39 | 0.8 (0.3-1.9) p=0.59 |
| Insulin delivery type | ||
| Injection | -- | -- |
| Pump | 2 (0.7-5.6) p=0.19 | 3.3 (1.1-10.4) p=0.04 |
Odds ratios (OR) for disease-specific risk factors included in the analyses of depression and anxiety prevalence by disease group are shown. Analysis of the SLEDAI variable was limited to 43 SLE/MCTD subjects with available data. Analysis of T1D-specific variables was limited to 42 T1D subjects with available data. Reference groups are denoted by “—”.